In the current study, in order to develop more potential drugs against AD, a series of novel AChE/BuChE inhibitors were synthesized based on the skeleton of DL0410 and evaluated for AChE and BuChE inhibitory activities. This evidence concerns the gene ACHE and Alzheimer disease.